US Broker Ratings

Repligen Corporation (RGEN) Stock Analysis: A Healthcare Standout with 13.3% Potential Upside

Repligen Corporation (NASDAQ: RGEN) is a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, the company..

Legend Biotech Corporation (LEGN) Stock Analysis: 151% Potential Upside Sparks Investor Interest

Legend Biotech Corporation (NASDAQ: LEGN) is capturing the attention of investors with its impressive potential upside of 151.08%. As a key player in the biotechnology sector,..

Bio-Techne Corp (TECH) Stock Analysis: Navigating an 11 Billion Dollar Market Cap Amid Modest Growth Challenges

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, is capturing significant attention from investors due to its robust market capitalization of $11.26 billion...

Grifols, S.A. (GRFS) Stock Analysis: Unpacking the 36.84% Potential Upside for Investors

Investors looking for opportunities in the healthcare sector might find Grifols, S.A. (NASDAQ: GRFS) an intriguing prospect. With a robust presence in the plasma-derived medicines market,..

Penumbra, Inc. (PEN) Stock Analysis: Evaluating the 11.45% Potential Upside in Medical Devices

As investors continuously seek out promising opportunities in the healthcare sector, Penumbra, Inc. (NYSE: PEN) emerges as a noteworthy player within the medical devices industry. With..

Illumina, Inc. (ILMN) Stock Analysis: Navigating Potential Upside in Genomic Innovation

For investors with a keen eye on the healthcare sector, Illumina, Inc. (NASDAQ: ILMN) presents a compelling narrative of innovation-driven growth. As a leader in the..

Doximity, Inc. (DOCS) Stock Analysis: Navigating a 7.34% Potential Upside in the Healthcare Sector

Doximity, Inc. (DOCS) stands as a compelling player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $4.88 billion,..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: A 14.95% Upside with Strong Buy Ratings

GE HealthCare Technologies Inc. (NYSE: GEHC) is making waves in the healthcare sector with its robust performance and promising growth potential. As a key player in..

Ascendis Pharma A/S (ASND) Stock Analysis: Unpacking a Promising 20% Upside Potential

Investors looking to tap into the burgeoning biotechnology sector should not overlook Ascendis Pharma A/S (NASDAQ: ASND), a dynamic player in the healthcare industry based in..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Exploring a 103% Potential Upside in the Biotech Sector

Summit Therapeutics Inc. (NASDAQ: SMMT), a biotechnology company with a market capitalization of $11.14 billion, is capturing investor attention with its promising pipeline and significant potential..

AptarGroup, Inc. (ATR) Stock Analysis: 25.64% Potential Upside Sparks Investor Interest

AptarGroup, Inc. (NYSE: ATR), a prominent player in the healthcare sector specializing in medical instruments and supplies, is catching the eye of investors with its promising..

HCA Healthcare, Inc. (HCA) Stock Analysis: Navigating a 9.68% Potential Upside Amid Strong Revenue Growth

HCA Healthcare, Inc. (NYSE: HCA) stands as a formidable player in the U.S. healthcare sector, commanding a market capitalization of $91.7 billion. As an investor, keeping..

Viatris Inc. (VTRS) Stock Analysis: Unveiling a 12.6% Potential Upside Amidst Strong Cash Flow

Viatris Inc. (NASDAQ: VTRS), with its extensive global footprint and diverse pharmaceutical portfolio, has emerged as a notable player in the healthcare sector. As the company..

BioMarin Pharmaceutical Inc. (BMRN) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Arena

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) stands as a formidable player in the biotechnology sector, renowned for its focus on developing therapies for life-threatening rare diseases. With..

Alcon Inc. (ALC) Stock Analysis: Tapping into a 21.6% Upside Potential in Healthcare Innovation

Alcon Inc. (NYSE: ALC), a global leader in eye care, presents an intriguing investment opportunity in the healthcare sector. Headquartered in Geneva, Switzerland, Alcon is renowned..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: A Biotech Powerhouse with Robust Revenue Growth and Strong Analyst Support

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been capturing investor attention with its impressive market performance and promising growth trajectory...

Veeva Systems Inc. (VEEV) Stock Analysis: Exploring Growth Potential with Analyst Ratings and Revenue Performance

Veeva Systems Inc. (NYSE: VEEV), a leading player in the healthcare sector, specifically within health information services, is capturing investor attention with its robust revenue growth..

DexCom, Inc. (DXCM) Stock Analysis: Exploring the 10.25% Potential Upside for Investors

DexCom, Inc. (NASDAQ: DXCM), a leader in the healthcare sector’s medical device industry, continues to capture investor attention with its innovative solutions in the diabetes management..

Biogen Inc. (BIIB) Stock Analysis: Uncovering a Potential 13% Upside

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector, particularly in the drug manufacturing industry, is attracting investor attention with its robust portfolio and..

Qiagen N.V. (QGEN) Investor Outlook: Analyzing Growth Potential with an 8.24% Upside

For investors interested in the healthcare sector, Qiagen N.V. (NYSE: QGEN) presents an intriguing opportunity with its current market dynamics and potential upside. Headquartered in Venlo,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds